Cargando…
Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation
Breast cancer stem cells (CSCs) are considered as the root of mammary tumorigenesis. Previous studies have demonstrated that ISL efficiently limited the activities of breast CSCs. However, the cancer prevention activities of ISL and its precise molecular mechanisms remain largely unknown. Here, we r...
Autores principales: | Wang, Neng, Wang, Zhiyu, Wang, Yu, Xie, Xiaoming, Shen, Jiangang, Peng, Cheng, You, Jieshu, Peng, Fu, Tang, Hailin, Guan, Xinyuan, Chen, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496402/ https://www.ncbi.nlm.nih.gov/pubmed/25918249 |
Ejemplares similares
-
Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway
por: Wang, Zhiyu, et al.
Publicado: (2013) -
iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
por: Gao, Fei, et al.
Publicado: (2017) -
Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2017) -
Author Correction: Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2023) -
MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin
por: Wang, Zhiyu, et al.
Publicado: (2014)